Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers-Reference-Cited by-同舟云学术

Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers

Published:2015-09 Issue:3 Volume:28 Page:384-398
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Peng Sheng-Bin,Henry James R.,Kaufman Michael D.,Lu Wei-Ping,Smith Bryan D.,Vogeti Subha,Rutkoski Thomas J.,Wise Scott,Chun Lawrence,Zhang Youyan,Van Horn Robert D.,Yin Tinggui,Zhang Xiaoyi,Yadav Vipin,Chen Shih-Hsun,Gong Xueqian,Ma Xiwen,Webster Yue,Buchanan Sean,Mochalkin Igor,Huber Lysiane,Kays Lisa,Donoho Gregory P.,Walgren Jennie,McCann Denis,Patel Phenil,Conti Ilaria,Plowman Gregory D.,Starling James J.,Flynn Daniel L.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference49 articles.

1. Single substitution within the RKTR motif impairs kinase activity but promotes dimerization of RAF kinase;Baljuls;J. Biol. Chem.,2011

2. c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma;Blasco;Cancer Cell,2011

3. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma;Bollag;Nature,2010

4. Vemurafenib: the first drug approved for BRAF-mutant cancer;Bollag;Nat. Rev. Drug Discov.,2012

5. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N. Engl. J. Med.,2011

Cited by 262 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapy Innovations for Melanoma;Hematology/Oncology Clinics of North America;2024-10

2. RAF inhibitors activate the integrated stress response by direct activation of GCN2;2024-08-16

3. Functional and structural insights into RAS effector proteins;Molecular Cell;2024-08

4. Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling;International Journal of Cancer;2024-07-12

5. Current State of Targeted Therapy in Adult Langerhans Cell Histiocytosis and Erdheim–Chester Disease;Targeted Oncology;2024-07-11